Cargando…
Research progress of STC2 in breast cancer
Breast cancer ranks second in the list of most common cancers among women and brings the double burden of economy and health to women. Therefore, it is an urgent and necessary task to study the pathogenic mechanism and the treatment of breast cancer. Glycoprotein hormone is a kind of hormones to pro...
Autores principales: | Niu, Xuezhi, Zhan, Yong, Zhang, Suhua, Liu, Zixin, Qu, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biophysics Reports Editorial Office
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244795/ https://www.ncbi.nlm.nih.gov/pubmed/37287492 http://dx.doi.org/10.52601/bpr.2021.210002 |
Ejemplares similares
-
Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression
por: Wang, Ziyue, et al.
Publicado: (2023) -
Upregulation of STC2 in colorectal cancer and its clinicopathological significance
por: Zhang, Chunxiao, et al.
Publicado: (2019) -
Effect of STC2 gene silencing on colorectal cancer cells
por: Li, Qianyuan, et al.
Publicado: (2019) -
Sevoflurane inhibits the progression of ovarian cancer through down-regulating stanniocalcin 1 (STC1)
por: Zhang, Chuanfeng, et al.
Publicado: (2019) -
CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription
por: Huang, Sheng, et al.
Publicado: (2018)